PE20050491A1 - Derivados de morfolina como inhibidores de la recaptacion de norepinefrina - Google Patents
Derivados de morfolina como inhibidores de la recaptacion de norepinefrinaInfo
- Publication number
- PE20050491A1 PE20050491A1 PE2004001093A PE2004001093A PE20050491A1 PE 20050491 A1 PE20050491 A1 PE 20050491A1 PE 2004001093 A PE2004001093 A PE 2004001093A PE 2004001093 A PE2004001093 A PE 2004001093A PE 20050491 A1 PE20050491 A1 PE 20050491A1
- Authority
- PE
- Peru
- Prior art keywords
- recaptation
- norepinephrine
- inhibitors
- alkyl
- morpholin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
REFERIDA A COMPUESTOS DE FORMULA I CARACTERIZADO PORQUE X ES OH, ALCOXI C1-C4, NH2, ENTRE OTROS; RX Y RY SON CADA UNO H, ALQUILO C1-C4; RZ SON CADA UNO H, ALQUILO C1-C4; R1 ALQUILO C1-C6, ALQUENILO C2-C6, CICLOALQUILO C3-C6, ENTRE OTROS; Ar1 ES FENILO, HETEROARILO DE 5 A 6 MIEMBROS, ENTRE OTROS. TAMBIEN REFERIDA A UNA COMPOSICION CUYOS COMPUESTOS SON INHIBIDORES DE LA RECAPTACION DE NOREPINEFRINA UTILES EN EL TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL Y/O PERIFERICO
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0326148.4A GB0326148D0 (en) | 2003-11-10 | 2003-11-10 | Morpholine derivatives |
US53545904P | 2004-01-09 | 2004-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20050491A1 true PE20050491A1 (es) | 2005-08-24 |
Family
ID=29726235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004001093A PE20050491A1 (es) | 2003-11-10 | 2004-11-09 | Derivados de morfolina como inhibidores de la recaptacion de norepinefrina |
Country Status (34)
Country | Link |
---|---|
US (1) | US7423037B2 (es) |
EP (2) | EP1682523B1 (es) |
JP (1) | JP4850068B2 (es) |
KR (1) | KR100783855B1 (es) |
CN (1) | CN1878762B (es) |
AR (1) | AR046927A1 (es) |
AT (1) | ATE478057T1 (es) |
AU (1) | AU2004289616B2 (es) |
BR (1) | BRPI0415273B8 (es) |
CA (1) | CA2544649C (es) |
CR (1) | CR8390A (es) |
CY (1) | CY1110796T1 (es) |
DE (1) | DE602004028750D1 (es) |
DK (1) | DK1682523T3 (es) |
EA (1) | EA009960B1 (es) |
EC (1) | ECSP066555A (es) |
ES (1) | ES2348872T3 (es) |
GB (1) | GB0326148D0 (es) |
HK (1) | HK1095135A1 (es) |
HR (1) | HRP20100476T1 (es) |
IL (1) | IL175365A (es) |
MA (1) | MA28330A1 (es) |
MY (1) | MY141048A (es) |
NO (1) | NO336268B1 (es) |
NZ (1) | NZ546067A (es) |
PE (1) | PE20050491A1 (es) |
PL (1) | PL1682523T3 (es) |
PT (1) | PT1682523E (es) |
SI (1) | SI1682523T1 (es) |
SV (1) | SV2006001934A (es) |
TW (1) | TWI339658B (es) |
UA (1) | UA85198C2 (es) |
WO (1) | WO2005047272A1 (es) |
ZA (1) | ZA200603680B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE399557T1 (de) * | 2003-12-12 | 2008-07-15 | Lilly Co Eli | Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen |
US8580776B2 (en) * | 2007-07-10 | 2013-11-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating neurodegenerating diseases |
RU2613633C1 (ru) * | 2016-03-09 | 2017-03-21 | федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) | Хлорид 4-[(1Е)-1-(6-хлор-4-оксо-4Н-хромен-3-ил)-4-метилпент-1-ен-3-ил]морфолин-4-ия, способ его получения и противотуберкулезная активность |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2645640A (en) | 1953-07-14 | Phenthiazine derivatives | ||
NL108827C (es) | 1956-04-09 | |||
GB895309A (en) | 1959-11-18 | 1962-05-02 | Res Lab Dr C Janssen Nv | Pyrrolidine and piperidine derivatives |
US3141823A (en) | 1962-09-04 | 1964-07-21 | Res Lab Dr C Janssen N V | Method for producing analgesia |
US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
JPS54130587A (en) | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
US4804663A (en) | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
IE58370B1 (en) | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
GB8607684D0 (en) | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
US4831031A (en) | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
GB8908085D0 (en) | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
US5238945A (en) | 1989-04-11 | 1993-08-24 | H. Lundbeck A/S | Method of treating psychoses |
US5229382A (en) | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5312925A (en) | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
EG23659A (en) | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
WO1999015177A1 (en) | 1997-09-23 | 1999-04-01 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
NZ520349A (en) * | 1998-01-21 | 2004-02-27 | Glaxo Group Ltd | (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2- morpholinol and its salts and pharmaceuticals thereof |
AU5889100A (en) | 1999-06-30 | 2001-01-31 | Merck & Co., Inc. | Src kinase inhibitor compounds |
DK1632234T3 (da) * | 1999-07-01 | 2007-09-17 | Pharmacia & Upjohn Co Llc | (S,S)-reboxetin til behandling af kronisk træthedssyndrom |
GB0120461D0 (en) * | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
GB0219687D0 (en) | 2002-08-23 | 2002-10-02 | Lilly Co Eli | Benzyl morpholine derivatives |
JP2004277318A (ja) * | 2003-03-14 | 2004-10-07 | Dainippon Pharmaceut Co Ltd | 1−(1−置換カルボニル−4−ピペリジニルメチル)ピペリジン誘導体およびそれを含有する医薬組成物 |
FR2852954B1 (fr) * | 2003-03-28 | 2006-07-14 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
-
2003
- 2003-11-10 GB GBGB0326148.4A patent/GB0326148D0/en not_active Ceased
-
2004
- 2004-10-22 TW TW093132096A patent/TWI339658B/zh active
- 2004-10-28 DE DE602004028750T patent/DE602004028750D1/de active Active
- 2004-10-28 CN CN2004800331155A patent/CN1878762B/zh active Active
- 2004-10-28 AU AU2004289616A patent/AU2004289616B2/en active Active
- 2004-10-28 US US10/577,841 patent/US7423037B2/en active Active
- 2004-10-28 DK DK04794209.9T patent/DK1682523T3/da active
- 2004-10-28 PT PT04794209T patent/PT1682523E/pt unknown
- 2004-10-28 CA CA2544649A patent/CA2544649C/en active Active
- 2004-10-28 JP JP2006539492A patent/JP4850068B2/ja active Active
- 2004-10-28 ES ES04794209T patent/ES2348872T3/es active Active
- 2004-10-28 EA EA200600945A patent/EA009960B1/ru unknown
- 2004-10-28 NZ NZ546067A patent/NZ546067A/en unknown
- 2004-10-28 EP EP04794209A patent/EP1682523B1/en active Active
- 2004-10-28 WO PCT/US2004/032771 patent/WO2005047272A1/en active Application Filing
- 2004-10-28 KR KR1020067008999A patent/KR100783855B1/ko active IP Right Grant
- 2004-10-28 UA UAA200604519A patent/UA85198C2/ru unknown
- 2004-10-28 PL PL04794209T patent/PL1682523T3/pl unknown
- 2004-10-28 SI SI200431540T patent/SI1682523T1/sl unknown
- 2004-10-28 BR BRPI0415273A patent/BRPI0415273B8/pt active IP Right Grant
- 2004-10-28 EP EP10162865A patent/EP2223916A1/en not_active Withdrawn
- 2004-10-28 AT AT04794209T patent/ATE478057T1/de active
- 2004-11-08 MY MYPI20044640A patent/MY141048A/en unknown
- 2004-11-09 PE PE2004001093A patent/PE20050491A1/es active IP Right Grant
- 2004-11-09 AR ARP040104126A patent/AR046927A1/es active IP Right Grant
- 2004-11-10 SV SV2004001934A patent/SV2006001934A/es unknown
-
2006
- 2006-05-01 IL IL175365A patent/IL175365A/en active IP Right Grant
- 2006-05-09 EC EC2006006555A patent/ECSP066555A/es unknown
- 2006-05-09 ZA ZA200603680A patent/ZA200603680B/en unknown
- 2006-05-10 CR CR8390A patent/CR8390A/es unknown
- 2006-06-02 MA MA29074A patent/MA28330A1/fr unknown
- 2006-06-12 NO NO20062700A patent/NO336268B1/no unknown
-
2007
- 2007-01-05 HK HK07100215.2A patent/HK1095135A1/xx unknown
-
2010
- 2010-08-31 HR HR20100476T patent/HRP20100476T1/hr unknown
- 2010-09-23 CY CY20101100858T patent/CY1110796T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
UY28150A1 (es) | Agentes terapeuticos | |
MX2009005449A (es) | Compuesto heteromonociclico y uso del mismo. | |
PE20070367A1 (es) | Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa | |
PE20060583A1 (es) | Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas | |
PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
PA8501801A1 (es) | Inhibidores triciclicos de polimerasas (adp - polirribosas) | |
MX2010008818A (es) | Derivado de bicicloamina. | |
PE20071136A1 (es) | Derivados de anilina sustituida como antagonistas de la histamina h3 | |
MY135841A (en) | Novel benzodioxoles | |
CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
NO20051826L (no) | Heterosyklisk substituerte piperaziner for behandling av schizofreni | |
MY153941A (en) | Compounds as bradykinin b1 antagonists | |
AR040278A1 (es) | Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos | |
DE60322877D1 (de) | Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität | |
PE20090890A1 (es) | Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
PE20141352A1 (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
TW200609224A (en) | Organic compounds | |
PE20110213A1 (es) | Derivados de indolinona como inhibidores de quinasa | |
TN2021000025A1 (en) | Novel heterocyclic amine derivative and pharmaceutical composition comprising same | |
SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
PE20050491A1 (es) | Derivados de morfolina como inhibidores de la recaptacion de norepinefrina | |
AR038342A1 (es) | Derivados piridin-amido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |